E
EFORL
vs
A
0HF3
Over the past 12 months, EFORL has underperformed 0HF3, delivering a return of -39% compared to the 0HF3's +51% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
E
|
E for L Aim PCL
SET:EFORL
|
0.14
THB
|
|||||
|
A
|
Amerisourcebergen Corp
LSE:0HF3
|
362.16
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
EFORL, 0HF3
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
E
|
E for L Aim PCL
Revenue
|
|||||||||||
|
A
|
Amerisourcebergen Corp
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
EFORL, 0HF3
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
E
|
E for L Aim PCL
SET:EFORL
|
|||||||||
|
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
E for L Aim PCL | ||||
|
A
|
Amerisourcebergen Corp | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
E for L Aim PCL | ||||
|
A
|
Amerisourcebergen Corp | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
E for L Aim PCL | ||||
|
A
|
Amerisourcebergen Corp | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
E for L Aim PCL | ||||
|
A
|
Amerisourcebergen Corp | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
EFORL, 0HF3
Performance By Year
EFORL, 0HF3
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Mckesson Corp
NYSE:MCK
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
| US |
|
Cencora Inc
NYSE:COR
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|